LAWSUITS NEWS & LEGAL INFORMATION
Drugs/MedicalSort by date
Lawsuits - Drugs/Medical
- FDA Issues Warning for Morphine Sulfate Oral Solution 100 mg per 5 mL
- FDA Issues Warning for Transvascular Autonomic Modulation (TVAM)
- FDA Issues Warning of Possible Serious CNS Reactions with Methylene Blue
- FDA Issues Warnings For Mammograms at Boston Diagnostic Imaging in Florida
- FDA Monitoring Savella (Milnacipran HC) for Suicidal Ideation
- FDA orders postmarket surveillance of certain TMJ implants
- FDA Places Loperamide HCl-containing products (Imodium) on Watchlist
- FDA Pulls Zofran 32 mg due to Potential For Serious Cardiac Risks
- FDA recalls All Custom Ultrasonics Automated Endoscope Reprocessors
- FDA Recalls Nova Max Blood Glucose Test Strips
- FDA Receives Hundreds of Complaints About Essure Contraceptive Coils
- FDA recibe cientos de quejas sobre el implante anticonceptivo Essure
- FDA Recommends Changes to Zocor (Simvastatin)Dosing due to Potential Kidney Problems
- FDA Reports Fatal Pneumothorax Events Linked to Two Enteral Feeding Tubes
- FDA Reports Indicate Ondansetron Linked to Birth Defects
- FDA Reviewing Safety of Mercury Amalgam Dental Fillings
- FDA Reviews Saxagliptin (Onglyza and Kombiglyze XR) For Heart Failure Risk
- FDA Revises Labeling on 5-alpha reductase inhibitors Over Prostate Cancer Risk
- FDA Seizes DDS Probiotic Products
- FDA Studying Stalevo for Risk of Prostate Cancer Risk
- FDA to Remove Breast Cancer Indication for Avastin
- FDA Updates Pregnancy Section Labeling for Antipsychotic Drugs
- FDA Wants More Data on Saxagliptin Dapagliflozin Combo Diabetes Medication
- FDA Warning Issued About Counterfeit Alli
- FDA Warning to DePuy Orthopaedics
- FDA Warns About Fraudulent Tamiflu
- FDA Warns About Serious Olanzapine Skin Reactions
- FDA warns consumers not to use Vigor-25
- FDA Warns Injectable Silicone not for Body Contouring and Enhancement
- FDA Warns Not to Use Stolen Advair Diskus Inhalers
- FDA Warns of Pulmonary Hypertension in Infants and Newborns Linked to Proglycem (diazoxide)
- FDA Warns of Abnormal Heart Rhythms with Anzemet
- FDA Warns of Adverse Events Associated with Post Surgical Intraocular Vancomycin
- FDA Warns of Birth Defects Associated with High Dose Diflucan (Fluconazole)
- FDA Warns of Continued High Death Rates with Syncardia Heart Transplant Devices
- FDA Warns of First Cases of PML Associated with MS Drug Gilenya
- FDA Warns of Fracture Risk with Invokana and Invokamet
- FDA Warns of Increased Risk of Invokana Leg and Foot Amputations
- FDA Warns of Infection Risk with Duodenoscope
- FDA Warns of Ketoacidosis Linked to SGLT2 inhibitors Canagliflozin, Dapagliflozin, and Empagliflozin
- FDA Warns of LIver Injury with Orlistat
- FDA Warns of Nizoral Liver Injury and Adrenal Gland Problems
- FDA Warns of Permanent Skin Color Changes with Daytrana Patch
- FDA Warns of Risk of Legionella and Listeria with Enbrel and other TNFa blockers
- FDA Warns of Risk of Oral Birth Defects in Children Born to Mothers Taking Topiramate
- FDA Warns of Serious Burns with Over-The-Counter Topical Muscle and Joint Pain Relievers
- FDA Warns Serious CNS Reactions Possible with Zyvox (linezolid)
- FDA Warns Warner over Ovcon Birth Control Effectivness
- FDA, Genzyme Issue Safety Alert for Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen
- FDA, Thomas Medical Issue Class 1 Recall of Coronary Sinus Guide Systems